Responders received a median of 18 cycles of treatment (range, 6C46)
Responders received a median of 18 cycles of treatment (range, 6C46). 24 months (IQR 173C369). In the thymoma cohort five (14%) of 37 patients (95% CI 5C29%) achieved a partial response, 28 had stable disease and four had progressive disease. Corresponding numbers for the thymic carcinoma cohort were zero of…